Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma

SE Serfling, Y Zhi, F Megerle, M Fassnacht, AK Buck… - Endocrine, 2022 - Springer
… At time of SSTR-directed PET/CT, calcitonin was median 1400 pg/ml (range, 26–42700) …
Upon referral by the treating physician, all patients underwent SSTR-directed PET/CT due to …

Somatostatin ReceptorDirected PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas

Y Zhi, E Gerhard-Hartmann, PE Hartrampf… - Clinical Nuclear …, 2023 - journals.lww.com
… Given their neuroendocrine origin, head and neck paragangliomas (HNPGLs) can be
imaged with somatostatin receptor (SSTR)–directed PET/CT. We aimed to determine …

[HTML][HTML] … somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT

M Cheng, M Tann - Hepatobiliary Surgery and Nutrition, 2022 - ncbi.nlm.nih.gov
Background Somatostatin receptor (SSTR)-targeted positron emission tomography/computed
tomography (PET/CT) imaging has risen to the forefront for neuroendocrine tumor (NET) …

Somatostatin receptor-directed PET/CT for therapeutic decision-making and disease control in patients affected with small cell lung cancer

SE Serfling, PE Hartrampf, Y Zhi, T Higuchi… - Clinical Nuclear …, 2023 - journals.lww.com
Somatostatin receptordirected PET/CT was performed because of suspected tumor
progression potentially requiring a change in therapy or to determine a rationale for PRRT. …

… practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

NL Albert, M Preusser, T Traub-Weidinger… - European Journal of …, 2024 - Springer
… SSTR-directed PRRT in meningioma has been investigated in small and uncontrolled …
expression of SSTR type 2 receptors on SSTR-directed PET imaging with potential clinical benefit […

High interobserver agreement for the standardized reporting system SSTR-RADS 1.0 on somatostatin receptor PET/CT

RA Werner, T Derlin, SP Rowe… - Journal of Nuclear …, 2021 - Soc Nuclear Med
… The theranostic concept in patients with neuroendocrine neoplasms (NENs) is based on
somatostatin receptor (SSTR)–directed imaging followed by systemic radiation with β-emitting …

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target

F Şen, GT Sheikh, J von Hinten, A Schindele, M Kircher… - Cancers, 2023 - mdpi.com
… SCLC underwent SSTR-directed PET/computed tomography (somatostatin receptor imaging,
SRI… In addition, subjects eligible for SSTR-directed radioligand therapy were identified, and …

Somatostatin receptor imaging PET in neuroendocrine neoplasm

CB Johnbeck, J Mortensen - PET clinics, 2021 - pet.theclinics.com
… All approved somatostatin receptor imaging tracers so far are agonists. Recent promising …
The impact of somatostatin receptor-directed PET/CT on the management of patients with …

Clinical applications of somatostatin receptor (agonist) PET tracers beyond neuroendocrine tumors

R Helgebostad, ME Revheim, K Johnsrud, K Amlie… - Diagnostics, 2022 - mdpi.com
… Patients with indications other than NETs and meningiomas who had diagnostic radiolabeled
somatostatin receptor analogue PET imaging, using DOTANOC, DOTATOC, DOTATATE …

Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma

L Zhao, Y Pang, Y Wang, J Chen, Y Zhuang… - European Journal of …, 2022 - Springer
Somatostatin (SST) is a cyclic disulphide-containing peptide hormone that binds somatostatin
receptors (SSTRs). SSTRs belong to the family of G protein–coupled receptors and have …